Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 9, 2012, Pages

  Mendes, Flavia D ^a   Suzuki, Ayako ^a   Sanderson, Schuyler O ^b   Lindor, Keith D ^a   Angulo, Paul ^a,c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Disease Progression; Obesity; Prognostic Factor; Steatosis

Indexed keywords

ADULT; ARTICLE; ASCITES; BRAIN DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; FIBROSIS; HUMAN; HYPERBILIRUBINEMIA; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PORTAL HYPERTENSION; PREVALENCE; SPLENOMEGALY; THROMBOCYTOPENIA;

EID: 84865316982     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.05.008     Document Type: Article

References (23)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
2. Kleiner D.E., Brunt E.M. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012, 32:3-13.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
4. Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005, 42:132-138.
5. Caldwell S.H., Oelsner D.H., Iezzoni J.C., et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664-669.
6. Poonawala A., Nair S.P., Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000, 32:689-692.
7. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005, 43:167-176.
8. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007, 46:922-938.
9. Niederau C., Sonnenberg A., Müller J.E., et al. Sonographic measurements of the normal liver, spleen, pancreas, and portal vein. Radiology 1983, 149:537-540.
10. Leopold G.R., Asher W.M. Fundamentals of abdominal and pelvic ultrasound 1975, WB Saunders, Philadelphia.
11. Bezerra A.S., D'Ippolito G., Faintuch S., et al. Determination of splenomegaly by CT: is there a place for a single measurement?. AJR Am J Roentgenol 2005, 184:1510-1513.
12. Inokuchi K. The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 1980, 10:84-87.
13. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
14. Shah V., García-Cardeña G., Sessa W.C., et al. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology 1998, 27:279-288.
15. McCuskey R.S., Ito Y., Robertson G.R., et al. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004, 40:386-393.
16. Shibayama Y., Nakata K. Role of septal fibrosis in development of hepatic circulatory disturbance in the presence of liver cell enlargement. Liver 1992, 12:84-89.
17. D'Amico G., Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology 2004, 39:30-34.
18. de Franchis R. Portal hypertension 2011, Wiley-Blackwell, West Sussex, UK.
19. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022. American Association for the Study of Liver Diseases.
20. Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:356-362.
21. Wanless I.R., Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990, 12:1106-1110.
22. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
23. Younossi Z.M., Gramlich T., Matteoni C.A., et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004, 2:262-265.